Drug utilization and off-label drug use among Spanish emergency room paediatric patients

Cristina Morales-Carpi1, Luis Estañ, Elena Rubio

  • 1CS Picassent, Agencia Valenciana de Salud, Valencia, Spain.

Insights

Off-label medicine use is common in paediatric emergency room patients, despite a low average number of prescriptions per child. Further paediatric research is needed for rational drug use in children.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Drug Utilization

Background:

  • Paediatric patients often receive medications with limited specific paediatric data.
  • Off-label drug use in children is a recognized clinical challenge.

Purpose of the Study:

  • To describe medication use patterns in paediatric emergency room patients.
  • To determine the frequency and types of off-label drug use in this population.

Main Methods:

  • A prospective, observational study was conducted in a Spanish hospital's paediatric emergency department.
  • Parental/guardian reports were used to analyze medicines prescribed to children under 14 years prior to their ER visit.
  • Off-label use was defined by deviations from the Summary of Product Characteristics regarding indication, dosage, frequency, route, or age group.

Main Results:

  • The study included 462 children, with 336 receiving 667 prescriptions.
  • Ibuprofen and paracetamol were the most frequent active principles.
  • 338 out of 667 prescriptions (approximately 50.7%) were classified as off-label, due to lack of paediatric information, contraindications, different indications, age inconsistencies, or dose/frequency issues.

Conclusions:

  • Off-label prescribing is frequent in paediatric emergency room patients.
  • There is a need for more paediatric-specific drug studies to ensure rational and safe medication use in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...